 Federal law requires limited inspections on no timetable. DHS maintains that the ``State's requirements for drug manufacturer licensing and the annual inspections may be considered a requirement in addition to the Federal requirement.''  What is the chairman's intent in this bill, as it addresses licensing and inspections by States?  